T. Fukui

Quantification of minimal residual disease in patients with e1a2 BCR-ABL-positive acute lymphoblastic leukemia using a real-time RT-PCR assay

Y. Tanaka, H. Hirai, K. Nakahara, 2002, Leukemia.

Treatment of Relapsing Ph+ Acute Lymphoblastic Leukemia with Donor Leukocyte Infusion Followed by Quantitative Monitoring of Residual Disease

K. Ohashi, H. Sakamaki, K. Hiruma, 2001, Hematology.

The Global DNA Methylation Surrogate LINE-1 Methylation Is Correlated with MGMT Promoter Methylation and Is a Better Prognostic Factor for Glioma

Y. Kondo, K. Wakai, Y. Nakasu, 2011, PloS one.

Localized Relapse in Bone Marrow in a Posttransplantation Patient with t(6;9) Acute Myeloid Leukemia

Y. Matsuzawa, H. Yoshida, J. Ishikawa, 2003, International journal of hematology.

[Study on the relationship between tumour necrosis factor gene polymorphism and prognosis in the patients with renal cell carcinoma].

K. Asano, Y. Ohishi, K. Imagawa, 1998, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.